Dr. Mahableshwarkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
One Takeda Parkway
Deerfield, IL 60015
Education & Training
ArMed Forces Medical College PuneClass of 1981
Certifications & Licensure
IL State Medical License 1987 - 2020
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- BTRX-246040 Study in Subjects With Parkinson's Disease With Motor Fluctuations Start of enrollment: 2018 Aug 31
Publications & Presentations
PubMed
- 5 citationsSuicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-te...Atul R. Mahableshwarkar, John Affinito, Elin Heldbo Reines, Judith Xu, George G. Nomikos
CNS Spectrums. 2020-06-01 - 34 citationsA phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia.Thomas A. Macek, Maggie McCue, Xinxin Dong, Elizabeth Hanson, Paul Goldsmith
Schizophrenia Research. 2019-02-01 - 10 citationsWhat is the overlap between subjective and objective cognitive impairments in MDDMaurizio Fava, Atul R. Mahableshwarkar, William Jacobson, Wei Zhong, Richard S.E. Keefe
Annals of Clinical Psychiatry. 2018-08-01
Press Mentions
Novel Drug Reduces Tics in Kids with Tourette SyndromeApril 7th, 2022- First Patient Dosed in Emalex Biosciences Phase 2 Clinical Trial for StutteringDecember 15th, 2020
- School of Medicine to Serve as Lead Site for Clinical Trial on StutteringDecember 15th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
